These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29350410)

  • 1. Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals.
    Mourez T; Decroos A; Goria O; Montialoux H; De Oliveira F; Larrat S; Plantier JC; Riachi G
    J Med Virol; 2018 May; 90(5):994-997. PubMed ID: 29350410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.
    Susser S; Dietz J; Schlevogt B; Zuckerman E; Barak M; Piazzolla V; Howe A; Hinrichsen H; Passmann S; Daniel R; Cornberg M; Mangia A; Zeuzem S; Sarrazin C
    J Hepatol; 2017 Oct; 67(4):680-686. PubMed ID: 28619439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.
    Zakalashvili M; Zarkua J; Weizenegger M; Bartel J; Raabe M; Zangurashvili L; Kankia N; Jashiashvili N; Lomidze M; Telia T; Kerashvili V; Zhamutashvili M; Abramishvili N; Hedskog C; Chodavarapu K; Brainard DM; McHutchison JG; Mo H; Svarovskaia E; Gish RG; Rtskhiladze I; Metreveli D
    Liver Int; 2018 Mar; 38(3):451-457. PubMed ID: 28782185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains.
    Trémeaux P; Caporossi A; Ramière C; Santoni E; Tarbouriech N; Thélu MA; Fusillier K; Geneletti L; François O; Leroy V; Burmeister WP; André P; Morand P; Larrat S
    Clin Microbiol Infect; 2016 May; 22(5):460.e1-460.e10. PubMed ID: 26827671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time.
    Cuypers L; Ceccherini-Silberstein F; Van Laethem K; Li G; Vandamme AM; Rockstroh JK
    Rev Med Virol; 2016 Nov; 26(6):408-434. PubMed ID: 27401933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report.
    Morel V; Descamps V; François C; Fournier C; Brochot E; Capron D; Duverlie G; Castelain S
    J Clin Virol; 2010 Apr; 47(4):382-6. PubMed ID: 20153975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential risk of misclassification HCV 2k/1b strains as HCV 2a/2c using VERSANT HCV Genotype 2.0 assay.
    De Keukeleire S; Descheemaeker P; Reynders M
    Diagn Microbiol Infect Dis; 2015 Jul; 82(3):201-2. PubMed ID: 25907374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.
    Mangia A; Susser S; Piazzolla V; Agostinacchio E; De Stefano G; Palmieri V; Spinzi G; Carraturo I; Potenza D; Losappio R; Arleo A; Miscio M; Santoro R; Sarrazin C; Copetti M
    J Hepatol; 2017 Apr; 66(4):711-717. PubMed ID: 27965158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prevalence of Mixed Hepatitis C Virus Genotype Infection and Its Effect on the Response to Direct-Acting Antivirals Therapy.
    Hayashi K; Tachi K; Shimizu Y; Nagano K; Ishizu Y; Kuzuya T; Honda T; Ishigami M; Hirooka Y; Hattori M; Goto H
    Intervirology; 2019; 62(1):23-29. PubMed ID: 31207601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy.
    Paolucci S; Premoli M; Ludovisi S; Mondelli MU; Baldanti F
    Antivir Ther; 2017; 22(4):365-368. PubMed ID: 28085002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2].
    Znoyko OO; Dudina KR; Kozina AN; Kalininа OV; Yushchuk ND
    Ter Arkh; 2016; 88(5):84-85. PubMed ID: 27239933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.
    Gaspareto KV; Ribeiro RM; de Mello Malta F; Gomes-Gouvêa MS; Muto NH; Mendes-Correa MC; Rozanski A; Carrilho FJ; Sabino EC; Pinho JR
    Arch Virol; 2016 Aug; 161(8):2161-8. PubMed ID: 27194536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845.
    Vijgen L; Thys K; Vandebosch A; Van Remoortere P; Verloes R; De Meyer S
    Virol J; 2017 May; 14(1):101. PubMed ID: 28569206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.
    Wilson EM; Kattakuzhy S; Sidharthan S; Sims Z; Tang L; McLaughlin M; Price A; Nelson A; Silk R; Gross C; Akoth E; Mo H; Subramanian GM; Pang PS; McHutchison JG; Osinusi A; Masur H; Kohli A; Kottilil S
    Clin Infect Dis; 2016 Feb; 62(3):280-288. PubMed ID: 26521268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of the VERSANT HCV genotype 2.0 assay.
    Yang R; Wei L
    Expert Rev Mol Diagn; 2018 Dec; 18(12):995-1004. PubMed ID: 30372355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6.
    Ku KS; Chodavarapu RK; Martin R; Miller MD; Mo H; Svarovskaia ES
    J Clin Microbiol; 2016 Jul; 54(7):1835-1841. PubMed ID: 27147726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV genotype 4, 5 and 6: Distribution of viral subtypes and sustained virologic response rates in clinical trials of approved direct-acting antiviral regimens.
    Boyd SD; Harrington P; Komatsu TE; Naeger LK; Chan-Tack K; Murray J; Birnkrant D; Struble K
    J Viral Hepat; 2018 Aug; 25(8):969-975. PubMed ID: 29577495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C treatment highlights from the 2011 American Association for the Study of Liver Disease meeting.
    Cooper C
    Clin Infect Dis; 2012 Aug; 55(3):418-25. PubMed ID: 22491342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failed triple therapy in a treatment-experienced patient with genotype 6 hepatitis C infection.
    Gammal RS; Spooner LM; Abraham GM
    Am J Health Syst Pharm; 2014 Feb; 71(3):204-8. PubMed ID: 24429013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.
    Furusyo N; Ogawa E; Nakamuta M; Kajiwara E; Nomura H; Dohmen K; Takahashi K; Satoh T; Azuma K; Kawano A; Tanabe Y; Kotoh K; Shimoda S; Hayashi J;
    J Hepatol; 2013 Aug; 59(2):205-12. PubMed ID: 23542346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.